Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Xenon Pharmaceuticals Inc."
Count: 15
Selected: 0
NCT IDTitle
NCT03796962A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
NCT05614063A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
NCT04912856An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
NCT04639310XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
NCT05376150A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
NCT04952467Single-dose Mass Balance Recovery and Metabolite Profile and Identification of 14C-XEN1101
NCT03467100Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901
NCT03340220Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN1101
NCT02656043A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
NCT03468725Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101
NCT01486446Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia
NCT01195636A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)
NCT00954356Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction
NCT01090622Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)
NCT00813670Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers